Biohit Oyj, Stock exchange release, April 30, 2018 at 11:00 am local time (EET)

M.Sc. (Econ) Jukka Kainulainen (b. 1982) has been appointed Chief Financial Officer and as a member of the Management Team of Biohit Oyj starting August 1st 2018. He will also be responsible for HR function and IT function. Kainulainen will report to CEO Semi Korpela. Kainulainen joins Biohit Oyj from CGI where he has worked as Business Controller responsible for Welfare and Local Government and Central Government business units. Before Suunto, Kainulainen has worked in several Finance leader and Controller positions at Affecto, Capgemini and Tieto.

Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com